Richard Lipton

3.7k total citations
59 papers, 1.5k citations indexed

About

Richard Lipton is a scholar working on Psychiatry and Mental health, Artificial Intelligence and Computational Theory and Mathematics. According to data from OpenAlex, Richard Lipton has authored 59 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Psychiatry and Mental health, 11 papers in Artificial Intelligence and 11 papers in Computational Theory and Mathematics. Recurrent topics in Richard Lipton's work include Migraine and Headache Studies (25 papers), Trigeminal Neuralgia and Treatments (9 papers) and Dementia and Cognitive Impairment Research (8 papers). Richard Lipton is often cited by papers focused on Migraine and Headache Studies (25 papers), Trigeminal Neuralgia and Treatments (9 papers) and Dementia and Cognitive Impairment Research (8 papers). Richard Lipton collaborates with scholars based in United States, Germany and Belgium. Richard Lipton's co-authors include Walter F. Stewart, Matthew S. Robbins, Mary Jean Harrold, Donglin Liang, Alessandro Orso, Fred D. Sheftell, Stephen D. Silberstein, Robert Ryan, Joel R. Saper and Steven Fortune and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Journal of the Mechanics and Physics of Solids.

In The Last Decade

Richard Lipton

48 papers receiving 1.4k citations

Peers

Countries citing papers authored by Richard Lipton

Since Specialization

Citations

This map shows the geographic impact of Richard Lipton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Lipton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Lipton more than expected).

Fields of papers citing papers by Richard Lipton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Lipton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Lipton. The network helps show where Richard Lipton may publish in the future.

Co-authorship network of co-authors of Richard Lipton

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Lipton. A scholar is included among the top collaborators of Richard Lipton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Lipton. Richard Lipton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The impact of neuroscience education therapy, behavioral economics, and digital navigators on patient migraine treatment adherence to a mobile health application: a prospective pilot randomized controlled trial 2025 ·PubMed ·Mia T. Minen, (unknown), John Torous, Jessica Fishman, Richard Lipton, Scott W. Powers	1
2	A 52‐week open‐label extension study to evaluate the safety and efficacy of oral rimegepant for the preventive treatment of migraine 2025 ·Headache The Journal of Head and Face Pain ·David Kudrow, Robert Croop, Alexandra Thiry, Richard Lipton	4
3	Influence of Birthplace and Age at Migration on Cognitive Aging Among Hispanic/Latino Populations in the United States: Study of Latinos-Investigation of Neurocognitive Aging 2025 ·The Gerontologist ·(unknown), Ariana M. Stickel, Wassim Tarraf, Li Li, Krista M. Perreira, Fernando Riosmena, Melissa Lamar, Fernando D. Testai, Linda C. Gallo, (unknown), Jorge J. Llibre‐Guerra, Carmen R. Isasi, Richard Lipton, Martha L. Daviglus, William H. Dow, Hector M. González	0
4	Assessing Stages of Objective Memory Impairment and neuroimaging as risk factors of incident cognitive impairment 2025 ·Journal of the International Neuropsychological Society ·(unknown), Ali Ezzati, (unknown), Richard Lipton, Reisa Sperling, Kathryn V. Papp, Dorene M. Rentz, Keith A. Johnson, Ellen Grober	0
5	Treatment effectiveness of galcanezumab versus traditional oral migraine preventive medications at 3 months: Results from the TRIUMPH study 2025 ·Headache The Journal of Head and Face Pain ·Richard Lipton, Miguel J. A. Láinez, Zubair Ahmed, (unknown), Diego Novick, Maurice Vincent, Lars Viktrup, R.L. Robinson	1
6	White matter hyperintensity burden mediates impact of vascular risk factors on cognitive impairment in SOL-INCA 2024 ·SHILAP Revista de lepidopterología ·Charles DeCarli, Pauline Maillard, Ariana M. Stickel, Wassim Tarraf, Kevin C. Gonzalez, Alejandra Morlett Paredes, Donglin Zeng, Jianwen Cai, Carmen R. Isasi, Robert C. Kaplan, Richard Lipton, Martha L. Daviglus, (unknown), Melissa Lamar, (unknown), (unknown), (unknown), (unknown), Stephan Seiler, (unknown)	0
7	Safety and tolerability of ubrogepant for the acute treatment of migraine in participants taking atogepant for the preventive treatment of episodic migraine: Results from the TANDEM study 2024 ·Headache The Journal of Head and Face Pain ·Jessica Ailani, Richard Lipton, Andrew Blumenfeld, Laszlo Mechtler, Brad Klein, (unknown), Jonathan H. Smith, Joel M. Trugman, (unknown), Elimor Brand‐Schieber	4
8	Atogepant for the preventive treatment of chronic migraine: results from the PROGRESS phase 3 trial (S47.005) 2023 ·Neurology ·Patricia Pozo‐Rosich, Jessica Ailani, Messoud Ashina, Peter J. Goadsby, Richard Lipton, Uwe Reuter, Hua Guo, Brittany Schwefel, Ramesh Boinpally, (unknown), Sung Yun Yu, Michelle Finnegan, Joel M. Trugman	4
9	A Phase 2/3 Open-label, Long-term, Safety Trial of Zavegepant 10 mg Nasal Spray for the Acute Treatment of Migraine (P9-12.002) 2023 ·Neurology ·Robert Croop, Jennifer Madonia, (unknown), (unknown), Meghan Lovegren, Richard Lipton	2
10	Prophylactic onabotulinumtoxinA in patients with chronic migraine and comorbid depression: An open-label, multicenter, pilot study of efficacy, safety and effect on headache-related disability, depression, and anxiety 2015 ·International Journal of General Medicine ·Guy Boudreau, Brian M. Grosberg, Peter J. McAllister, Richard Lipton, Dawn C. Buse	51
11	Realizable paths and the nl vs l problem 2011 ·Electronic colloquium on computational complexity ·Richard Lipton, Shiva Kintali	1
12	Robust norms for selected neuropsychological tests in older adults 2008 ·Archives of Clinical Neuropsychology ·Roee Holtzer, Yelena Goldin, Marc A. Zimmerman, Michael B. Katz, Herman Buschke, Richard Lipton	80
13	Deterministic identity testing for multivariate polynomials 2003 ·Symposium on Discrete Algorithms ·Richard Lipton, Nisheeth K. Vishnoi	13
14	Efficacy and Safety of Acetaminophen, Aspirin, and Caffeine in Alleviating Migraine Headache Pain 1998 ·Archives of Neurology ·Richard Lipton, Walter F. Stewart, Robert Ryan, Joel R. Saper, Stephen D. Silberstein, Fred D. Sheftell	168
15	Free and cued selective reminding and selective reminding in the elderly 1997 ·Journal of Clinical and Experimental Neuropsychology ·Ellen Grober, (unknown), (unknown), Richard Lipton	59
16	Online interval scheduling 1994 ·Symposium on Discrete Algorithms ·Richard Lipton	87
17	Epidemiology of Migraine 1993 ·Neuroepidemiology ·(unknown), Richard Lipton	80
18	Prophylactic Therapy of Cluster Headaches 1991 ·Clinical Neuropharmacology ·(unknown), Richard Lipton, Lawrence C. Newman	10
19	Unbounded fan-in circuits and associative functions 1985 ·Journal of Computer and System Sciences ·Ashok K. Chandra, Steven Fortune, Richard Lipton	38
20	Proceedings of the 8th ACM SIGPLAN-SIGACT symposium on Principles of programming languages 1981 ·John R. White, Richard Lipton, (unknown)	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact